Medical Product Outsourcing

Cardiovascular

Abbott's Latest HeartMate LVAD Recall Linked to 14 Deaths

The recall was made because of an issue called extrinsic outflow graft obstruction.

Sam Brusco, Associate Editor 04.16.24

Cardiovascular

Abbott's TriClip TEER Wins FDA Approval

The TriClip transcatheter edge-to-edge repair system is designed for treating tricuspid regurgitation.

Sam Brusco, Associate Editor 04.02.24

Diagnostics | Neurological

Abbott's Rapid Concussion Test OK'ed for Whole Blood

The test assesses patients with suspected concussion at the bedside and gets lab-quality results in 15 minutes.

Sam Brusco, Associate Editor 04.02.24

Cardiovascular | Patient Monitoring

Abbott Gets CE Mark for Assert-IQ Insertable Cardiac Monitor

Assert-IQ ICM helps doctors monitor people's heart rhythms remotely for up to six years.

Sam Brusco, Associate Editor 03.25.24

Cardiovascular

Abbott Enrolls 1st Patient in Navitor TAVI Trial for Low and Intermediate Surgical Risk

The Navitor TAVI features a NaviSeal fabric cuff that reduces blood backflow around the heart valve.

Sam Brusco, Associate Editor 03.22.24

Chronic Disease | Patient Monitoring

Asking Abbott Labs About Diabetes Technology

MPO recently spoke to a spokesperson from Abbott Laboratories about the company's technology.

Online Exclusives Sam Brusco, Associate Editor 03.21.24

Chronic Disease | Patient Monitoring

Abbott's Real-World Data Backs FreeStyle Libre CGM Use with GLP-1s

People with Type 2 diabetes had a greater HbA1c reduction when using GLP-1 drugs and FreeStyle Libre tech together.

Sam Brusco, Associate Editor 03.06.24

Cardiovascular

FDA Votes in Favor of Abbott's TriClip TEER for Tricuspid Regurgitation

Abbott said the agency’s decision on TriClip is anticipated in 2024.

Sam Brusco, Associate Editor 02.14.24

Neurological

Abbott's Liberta RC Deep Brain Stimulator Gets FDA Nod

Abbott said Liberta RC is the world's smallest rechargeable DBS device.

Sam Brusco, Associate Editor 01.25.24

Cardiovascular

Abbott Completes First Procedures with Volt Pulsed Field Ablation

Abbott anticipates FDA approval for its U.S. IDE clinical trial for Volt in H1 2024.

Sam Brusco, Associate Editor 01.18.24

Chronic Disease | Patient Monitoring

Abbott Integrates FreeStyle Libre 2 Plus CGM with Tandem's t:slim X2 Insulin Pump

Tandem’s pump connects wirelessly to the sensor, which sends automatic glucose readings every minute to the pump.

Sam Brusco, Associate Editor 01.08.24

Diagnostics

Abbott's 'Smart CAR' Lab Automation System Wins FDA Nod

GLP systems Track touts an intelligent, self-propelled single sample carrier called CAR.

Sam Brusco, Associate Editor 12.14.23

Cardiovascular | Patient Monitoring

Early Warning: A Q&A with Abbott's CMO of Heart Failure

Abbott’s connected care technology builds more collaboration between clinical teams and patients, helping treat heart failure before it worsens.

Online Exclusives Sam Brusco, Associate Editor 11.27.23

Cardiovascular

Abbott Trial Data Shows Aspirin-Free Regimen Helps HeartMate 3 Users

Patients had fewer bleeding complications and were associated with fewer hospital visits compared to those who took aspirin.

Sam Brusco, Associate Editor 11.13.23

Cardiovascular

Abbott Releases Aveir Dual-Chamber Pacemaker with Initial U.S. Procedures

Aveir DR's approval marked the first FDA nod for a dual-chamber, leadless pacing system to treat slow or abnormal heart rhythms.

Sam Brusco, Associate Editor 11.08.23

Diagnostics

Abbott Gains FDA Nod for HPV Test on Alinity m

The test offers primary HPV screening and assessment of high-risk, cancer-causing types of HPV.

Sam Brusco, Associate Editor 11.02.23

Cardiovascular | Surgical

First U.S. Procedure Completed with Combined Abbott, Stereotaxis Tech

The first U.S. patients were treated using Abbott’s EnSite X EP system with Stereotaxis' Robotic Magnetic Navigation system.

Sam Brusco, Associate Editor 10.31.23

Cardiovascular

Abbott, Damar Hamlin Team Up for New HeartMates Program

HeartMates aims to create a supportive, empowering community for people impacted by heart conditions.

Sam Brusco, Associate Editor 10.31.23

Cardiovascular

New Data Shows Abbott's Esprit BTK is Superior to Balloon Angioplasty in Treating CLTI

The trial data underscores the impact that Esprit BTK could have for millions with peripheral artery disease.

Charles Sternberg, Associate Editor 10.26.23

Cardiovascular

Abbott Shares Data Showing the Benefits of Its Minimally Invasive Heart Devices

Data includes findings from the TRILUMINATE pivotal trial and the MitraClip EXPAND G4 real-world registry.

Charles Sternberg, Associate Editor 10.25.23

Chronic Disease

Abbott Completes Acquisition of Bigfoot Biomedical

The transaction for Bigfoot expands Abbott’s presence in diabetes care.

Sam Brusco, Associate Editor 09.22.23

Chronic Disease | Digital Health

Abbott, WeightWatchers Release App for Type 2 Diabetes Patients

WeightWatchers members can access glucose data from FreeStyle Libre 2 while being guided by the plan.

Sam Brusco, Associate Editor 09.19.23

Chronic Disease

Abbott and Bigfoot Biomedical Finally Get Hitched

Abbott and Bigfoot have collaborated on connected diabetes solutions since 2017.

Sam Brusco, Associate Editor 09.06.23

Cardiovascular

Abbott Data Shows OCT Imaging Yields Better Stent Placement Outcomes

Data from Abbott's landmark ILUMIEN IV trial was presented at the European Society of Cardiology Congress.

Sam Brusco, Associate Editor 08.28.23

Diagnostics

Abbott's Alinity h-series Lab Instruments OK'ed for Complete Blood Counts

According to Abbott, complete blood counts (CBCs) are one of the most ordered tests in the healthcare system.

Sam Brusco, Associate Editor 08.07.23

Cardiovascular

Abbott Recalls Amplatzer Steerable Delivery Sheath for Air Embolism Risk

Air embolism can cause injuries like acute reduction in blood flow to the heart.

Sam Brusco, Associate Editor 07.28.23

Abbott

...

07.20.23

Cardiovascular

Combined Stereotaxis, Abbott Tech Treats First Arrhythmia Patients

Abbott’s EnSite X EP cardiac mapping was used with Stereotaxis' robotic magnetic navigation system.

Sam Brusco, Associate Editor 07.18.23

Cardiovascular

Abbott's Dual Chamber, Leadless Pacemaker Earns FDA Approval

Aveir DR enables the world's first beat-to-beat, wireless communication and synchronization between two leadless pacemakers.

Sam Brusco, Associate Editor 07.05.23

Abbott Appoints Philip Boudreau as New CFO

Boudreau has been Abbott’s vice president, controller since 2020.

Sam Brusco, Associate Editor 06.13.23

Cardiovascular | Patient Monitoring

Study Shows Abbott's CardioMEMS Sensor Almost Halves Heart Failure Hospitalizations

There was also significant improvement in patient-reported quality of life scores as early as three months after using the remote monitoring sensor.

Sam Brusco, Associate Editor 05.24.23

Cardiovascular

Study Backs Abbott's Dual-Chamber, Leadless Pacemaker

Over 97% of participants achieved successful atrio-ventricular (AV) synchrony.

Sam Brusco, Associate Editor 05.23.23

Cardiovascular | Patient Monitoring

Abbott, Stereotaxis to Combine Heart Mapping and Robotic Technologies

The two companies aim to improve treatment of abnormal heart rhythms.

Sam Brusco, Associate Editor 05.19.23

Cardiovascular | Surgical

FDA Approves Abbott's TactiFlex Ablation Catheter for Abnormal Heart Rhythm

According to Abbott, it’s the world’s first ablation catheter with flexible tip and contact force technology.

Sam Brusco, Associate Editor 05.19.23

Cardiovascular | Diagnostics | Patient Monitoring

Abbott's Assert-IQ ICM Earns FDA Nod

The insertable cardiac monitor (ICM) offers up to six years of battery life.

Sam Brusco, Associate Editor 05.18.23

Cardiovascular | Surgical

Abbott Releases Favorable, Late-Breaking Data for TriClip

Data presented at EuroPCR 2023 demonstrate TriClip is a safe and effective therapy to treat leaky tricuspid valves.

Sam Brusco, Associate Editor 05.17.23

Abbott Receives New Clearances from FDA for Life Support System

New indications will help doctors treat more critically ill patients.

Charles Sternberg, Associate Editor 04.25.23

Chronic Disease | Patient Monitoring

Medicare CGM Coverage Changes Help Dexcom, Abbott

Continuous glucose monitor (CGM) coverage was expanded April 16 to more patients with type 2 diabetes.

Sam Brusco, Associate Editor 04.17.23

Chronic Disease | Patient Monitoring

Abbott's FreeStyle Libre 3 Reader Wins FDA Nod

Abbott is working to have the FreeStyle Libre 3 system available to Medicare beneficiaries who use insulin.

Sam Brusco, Associate Editor 04.14.23

Chronic Disease | Patient Monitoring

Abbott Recalls Some FreeStyle Libre Readers Over Battery Issues

Batteries may get very hot, spark, or catch fire if not correctly stored, charged, or used with Abbott-provided USB cable and power adapter.

Sam Brusco, Associate Editor 04.11.23

Cardiovascular

FDA Approves Abbott's Epic Max Tissue Valve for Aortic Valve Disease

The stented tissue valve is intended to treat patients with aortic regurgitation or stenosis.

Sam Brusco, Associate Editor 03.30.23

Cardiovascular

Medinbox and Abbott Partner to Increase Efficiency in Electrophysiology Labs

Aim to strengthen information sharing among physicians to drive improved patient care.

Charles Sternberg, Associate Editor 03.28.23

Cardiovascular

Abbott's CardioMEMS HF System Helps Manage Heart Failure

New clinical data shows remote pressure monitoring can improve heart failure patient survival by 25%.

Charles Sternberg, Associate Editor 03.22.23

Diagnostics | Neurological

Abbott's Lab-Based Concussion Blood Test Earns FDA Nod

Test helps doctors evaluate patients with mild traumatic brain injury, commonly known as concussion.

Sam Brusco, Associate Editor 03.07.23

Chronic Disease | Patient Monitoring

Abbott's FreeStyle 2 & 3 iCGM Sensors OK'ed for Automated Insulin Delivery Systems

Sensors also cleared for children as young as two years old, pregnant women with diabetes, and wear time up to 15 days.

Sam Brusco, Associate Editor 03.06.23

Cardiovascular | Surgical

Abbott Releases Late-Breaking Data for Minimally Invasive Heart Devices

Demonstrates safety of Navitor TAVI system; benefits of Amplatzer Amulet LAA occluder.

Sam Brusco, Associate Editor 02.28.23

Cardiovascular | Surgical

Chronic Disease | Neurological

Abbott's Proclaim XR SCS OK'ed for Diabetic Neuropathy

The Proclaim XR SCS provides an alternative to traditional treatment approaches like oral medication.

Sam Brusco, Associate Editor 01.26.23

FOLLOW:

Search Results for 'abbott'

May 2024

follow us